AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- Iptacopan (Fabhalta) slowed kidney function decline in adults with immunoglobulin A (IgA) nephropathy, according to final data from the phase III APPLAUSE-IgAN study. The study met its primary endpoint, showing an annualized...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- NEW ORLEANS -- It may be reasonable for people with atrial fibrillation (Afib) to undergo percutaneous left atrial appendage (LAA) closure even if long-term anticoagulation is an alternative, according to the large CHAMPION...
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
(MedPage Today) -- NEW ORLEANS -- Evolocumab (Repatha) reduced risk of a first major cardiovascular (CV) event in patients with diabetes but no known atherosclerosis in a substudy of the VESALIUS-CV trial. The PCSK9 inhibitor cut relative risk...
(MedPage Today) -- NEW ORLEANS -- A major advance for the treatment of intermediate-risk pulmonary embolism (PE) arrived with HI-PEITHO's landmark report on ultrasound-facilitated, catheter-directed thrombolysis (CDT). In this hard-to-treat...